Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). [electronic resource]
- Leukemia research 10 2016
- 108-12 p. digital
Publication Type: Journal Article
1873-5835
10.1016/j.leukres.2016.08.006 doi
Adolescent Adult Aged Female Humans Imatinib Mesylate--pharmacology Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Male Middle Aged Mutagenesis, Insertional Protein Kinase Inhibitors--therapeutic use RNA Splicing--genetics Retrospective Studies Sequence Analysis, DNA Treatment Failure Young Adult